Skip to content

A randomized controlled study of acupuncture in the treatment of diarrhea-predominant irritable bowel syndrome

A randomized controlled study of acupuncture in the treatment of diarrhea-predominant irritable bowel syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006702
Enrollment
Unknown
Registered
2022-10-13
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

observation group:Acupuncture at Tianshu, Shangjuxu and Neiguan points
control group:Acupuncture at Tianshu, Shangjuxu, Zusanli points

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Persons aged 18-70 years old, regardless of gender; (2) Those who meet the above diagnostic criteria of IBS-D Rome IV; have typical symptoms of IBS-D; (3) The course of the disease exceeds 6 months; (4) The total score of the IBS Severity Scale at the baseline period is =75 points; (5) Patients with mild or moderate depression or anxiety, that is, those with a GAD-7 total score of 5-15, or a PHQ-9 total score of 5-15; (6) Normal cognitive function, good compliance, willing to cooperate with the research, voluntarily participate in this trial and sign the informed consent. Note: Inclusion only if all the above conditions are met.

Exclusion criteria

Exclusion criteria: (1) Those who meet the diagnostic criteria of IBS-C, IBS-M, and IBS-U Rome IV; (2) Those who have been diagnosed with organic diseases of the digestive system in the past, such as inflammatory bowel disease, intestinal tuberculosis, intestinal tumors, etc.; (3) Patients with severe heart, cerebrovascular system, liver, kidney, hematopoietic system, endocrine system, and rheumatic immune system in the past; (4) Severe mental illness and obvious cognitive impairment in the past; (5) Patients who have received acupuncture treatment in the past three months; (6) Pregnant or lactating women; (7) Patients who are participating in other clinical studies. Note: All patients who meet any one of the above items will be excluded.

Design outcomes

Primary

MeasureTime frame
VSI;GAD-7;PHQ-9;IBS-QOL;PQSI;EEG;IBS-SSS;

Countries

China

Contacts

Public ContactZhigang Li
drtianjunjian@163.com13693631588

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026